Trials / Completed
CompletedNCT03127384
Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars
A Randomised, Evaluator-blind Comparative Study to Evaluate Performance and Safety of Restylane Lidocaine and No-treatment Control for Treatment of Depressed Facial Acne Scars
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate performance and safety of Restylane Lidocaine for treatment of depressed facial acne scars
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane Lidocaine | Hyaluronic acid based filler |
| OTHER | No-treatment control | No-treatment control |
Timeline
- Start date
- 2017-04-20
- Primary completion
- 2018-02-15
- Completion
- 2018-11-08
- First posted
- 2017-04-25
- Last updated
- 2022-08-26
- Results posted
- 2019-10-03
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03127384. Inclusion in this directory is not an endorsement.